RecruitingISRCTN78948497
This study is recruiting in Uganda. It focuses on Schizophrenia.
In UgandaSchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Uganda
- Sponsor
- Queen Mary University of London
- Condition
- Schizophrenia
RecruitingISRCTN25146122
This study is recruiting in Uganda. It focuses on Schizophrenia.
In UgandaSchizophrenia, Depression, ...OtherFrom 18 Years to 65 Years
- Countries
- Uganda
- Sponsor
- Queen Mary University of London
- Condition
- Schizophrenia, Depression, ...
RecruitingISRCTN53107879
This study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomSchizophreniaOther
- Countries
- United Kingdom
- Sponsor
- Sussex Partnership NHS Foundation Trust
- Condition
- Schizophrenia
RecruitingNCT07226895
This study is recruiting in the United States. It focuses on Schizophrenia.
Multiple locations, including IrvineSchizophreniaDrugA study involving a medication or substance.From 17 Years to 30 Years
- Countries
- United States
- Sponsor
- Monument Therapeutics Limited
- Condition
- Schizophrenia
RecruitingISRCTN47913690
This study is recruiting in the United Kingdom. It focuses on Schizophrenia.
In United KingdomSchizophreniaOtherFrom 16 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- Pennine Care NHS Foundation Trust
- Condition
- Schizophrenia
RecruitingNCT07410507
This study is recruiting in the United States, in Argentina, in Brazil, .... It is testing brenipatide for schizophrenia.
Multiple locations, including Little RockSchizophreniaDrugFrom 18 Years to 55 Years
- Countries
- United States, Argentina, Brazil, ...
- Sponsor
- Eli Lilly and Company
- Condition
- Schizophrenia
RecruitingISRCTN49569866
This study is recruiting in India. It is testing effect of transcranial magnetic stimulation on cerebellum vermis for schizophrenia.
In IndiaSchizophreniaOtherOver 18 Years
- Countries
- India
- Sponsor
- Shri Guru Ram Rai Institute
- Condition
- Schizophrenia
RecruitingNCT07615426
This study is recruiting in the United States. It is testing aticaprant for schizophrenia.
Multiple locations, including Garden GroveSchizophreniaDrugFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Schizophrenia
RecruitingNCT06657430
This study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
In ShanghaiSchizophrenia, BipolarityOtherOver 18 Years
- Countries
- China
- Sponsor
- Shanghai Mental Health Center
- Condition
- Schizophrenia, Bipolarity
RecruitingISRCTN96331501
This study is recruiting. It focuses on schizophrenia and currently lists participation information in China.
In ChinaSchizophreniaOtherOver 18 Years
- Countries
- China
- Sponsor
- Wuhan Wudong Hospital
- Condition
- Schizophrenia
RecruitingNCT07145918
This study is recruiting in the United States. It is testing adverse Events, Change for schizophrenia.
Multiple locations, including Little RockSchizophreniaDrugFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- AbbVie
- Condition
- Schizophrenia
RecruitingNCT05511363
This study is recruiting in the United States, in France, in the United Kingdom, .... It is testing KarXT for Schizophrenia.
Multiple locations, including HomewoodSchizophreniaDrugFrom 55 Years to 90 Years
- Countries
- United States, France, United Kingdom, ...
- Sponsor
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
- Condition
- Schizophrenia
